BioSpace News Archive

Press Releases

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025

January 9, 2025
·
1 min read
Press Releases

U.S. FDA Confirms Class 1 Resubmission of the Supplemental New Drug Application for IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy

January 9, 2025
·
5 min read
Press Releases

Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma

January 9, 2025
·
10 min read
Press Releases

Verdiva Bio, a New Clinical-Stage Cardiometabolic Company, Launches with Over $410M in Series A Financing to Advance Next-Generation Therapies

January 9, 2025
·
5 min read
Press Releases

Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines

January 9, 2025
·
6 min read
Press Releases

MitoRx Therapeutics Expands Leadership Team with Strategic Appointments of Chief Business Officer and Finance Director

January 9, 2025
·
4 min read
Press Releases

European Commission Approves the Extension of the Indication of Palforzia® to the Treatment of Toddlers With Confirmed Peanut Allergy

January 9, 2025
·
5 min read
Press Releases

Multi-million Dollar Donation Propels Breast Cancer Vaccines Forward

January 9, 2025
·
3 min read
Press Releases

Dyne Therapeutics to Host Investor Conference Call and Webcast to Review New Clinical Data from the ACHIEVE Trial Friday, January 10 at 8:00 a.m. ET

January 9, 2025
·
1 min read
Press Releases

Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 9, 2025
·
3 min read